MedTrace Logo

Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure

NCT06080438 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2024-12-05

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to test if Topical (applied to the surface of the eye) Botulinum Toxin temporarily lowers the upper eyelid and makes the eyelid appear less open and thereby affects the eye surface and decreases reflexive tearing.

Conditions

  • Tears; Excess
  • Eyelid Spasm

Interventions

DRUG

Botulinum toxin

15 units of botulinum toxin administered one time to the eye via eye drops

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Wendy Lee, MD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-29
Primary Completion
2024-07-28
Completion
2024-07-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06080438 on ClinicalTrials.gov